Show sidebar

ArthroVisc 40

ArthroVisc®40 is a non-cross-linked hyaluronic acid (2 %) obtained from bacterial fermentation. This product is sterile and non-pyrogenic. It is packaged in 2 ml syringes of hyaluronic acid ( 20 mg/ml, 1500 KDa). ArthroVisc®40 is available in three syringes of 2 ml. It is for single use and designed to be used with sterile needles (25G or 27G), not supplied in the kit. Composition : 2 mL of solution contains 40mg of hyaluronic acid in phosphate buffer (Sodium chloride, Dipotassium hydrogenphosphate, Potassium dihydrogenphosphate, Potassium chloride) and water for injection.
Read more
Quick view
-14%

C+E Max

, ,
Original price was: S/350.00.Current price is: S/300.00.
Thanks to its powerful action that stimulates collagen formation, it helps reduce wrinkles and expression lines, promoting skin hydration and cell regeneration from the inside. Its liquid presentation means that collagen is absorbed more easily and quickly by the body and distributed to the deepest layers of the skin. Collagen production decreases from the age of 25. After the age of 40, it is reduced to 1%, which implies associated cellular aging, since the capacity to regenerate that collagen is lower. BENEFITS:
  • Reduces signs of aging. Protects against stress and oxidative damage.
  • Helps improve the elasticity and flexibility of the skin.
  • Helps skin look young, soft and smooth.
  • Strengthens the health of nails, preventing cuticle deterioration.
  • Improves hair fibers, prevents hair breakage
Add to cart
Quick view

Cellular Matrix A-CP-HA

Cellular Matrix® tubes allow the preparation of autologous platelet-rich plasma (RegenPRP®) combined with non-cross-linked hyaluronic acid (HA) in a closed-loop system. CM-PRP-HA has an excellent safety profile in clinical practice. Cellular Matrix® technology combines the complementary clinical effects of RegenPRP® and hyaluronic acid (HA), providing better, longer-lasting results in patients with osteoarthritis. Hyaluronic acid
  • Hyaluronic acid is an important component of synovial fluid that contributes to joint homeostasis.
  • 25 years of clinical experience shows pain relief and functional improvement lasting 6 to 12 months in patients with OA.
  • It plays an important role in viscosupplementation and pain relief in OA.
  • The network of HA chains generates an ideal matrix for cells when combined with PRP.
  • Hyaluronic acid enhances the activity of several molecules contained in platelet-rich plasma to provide additional benefits to OA patients.
Read more
Quick view

Cellular Matrix BCT-HA

Cellular Matrix® tubes allow the preparation of autologous platelet-rich plasma (RegenPRP®) combined with non-cross-linked hyaluronic acid (HA) in a closed-loop system. CM-PRP-HA has an excellent safety profile in clinical practice. Cellular Matrix® technology combines the complementary clinical effects of RegenPRP® and hyaluronic acid (HA), providing better, longer-lasting results in patients with osteoarthritis. Hyaluronic acid
  • Hyaluronic acid is an important component of synovial fluid that contributes to joint homeostasis.
  • 25 years of clinical experience shows pain relief and functional improvement lasting 6 to 12 months in patients with OA.
  • It plays an important role in viscosupplementation and pain relief in OA. The network of HA chains generates an ideal matrix for cells when combined with PRP.
  • Hyaluronic acid enhances the activity of several molecules contained in platelet-rich plasma to provide additional benefits to OA patients.
Read more
Quick view